Commentary
Commentaries are short perspectives by experts on AJKD articles or nephrology news.
There has been significant interest in SGLT2 inhibitors (SGLT2i) as novel oral anti-hyperglycemic agents that have been recently approved for the treatment of type 2 diabetes mellitus (T2DM). Studies such as CANVAS allude to their glucose-lowering
[read more...]Shared decision-making, an approach in which clinicians and patients partner to evaluate best available evidence for treatment options, discuss risks and benefits, and make informed decisions that align with goals and values, is a central tenet of
[read more...]Chronic kidney disease (CKD) is a growing problem worldwide, and as highlighted in NephMadness 2016, there is a relatively new form of CKD of nontraditional etiology in Central America, a nephropathy called mesoamerican nephropathy (MeN). In the
[read more...]What would you think about a drug that has been covered in the New York Times, 60 Minutes, CNN, and Forbes? Surely it’s a blockbuster and cures cancer, prevents heart attacks, or perhaps even prevents kidney failure? However, when you hear that
[read more...]The United States Secretary of Health & Human Services, Alex Azar, recently highlighted in a speech at the National Kidney Foundation’s Kidney Patient Summit the fact that due to misaligned financial incentives, we are paying for kidney
[read more...]An arteriovenous fistula (AVF) is a unique vascular structure leading to distinctive endothelial insults which may contribute to non-maturation or failure of the access. Up to 50% of AVFs undergo aberrant remodeling leading to stenotic segments,
[read more...]The association between sickle cell disease (SCD) and chronic kidney disease (CKD) is well known. A disease of recurrent vascular occlusion due to sickling red cells, the renal risk from such occlusive events is not to be understated. The kidney is
[read more...]In 1984, the United States Congress passed the National Organ Transplant Act that called for a national network to coordinate the procurement and allocation of organs for transplantation and for the collection of clinical data related to
[read more...]Despite our current understanding regarding the pathophysiology of autosomal dominant polycystic kidney disease (ADPKD), only one therapy has been approved by the US FDA. There has been recent interest in redefining end points for clinical trials
[read more...]Congo red is synonymous with amyloidosis. The visually stunning apple green birefringence lights up the eyes and minds of pathologists and nephrologists. Like many histological stains, Congo red was originally a textile dye that was later used to
[read more...]
